MOBSTA is a robustness testing tool for ROS that tests autonomous systems under realistic but rare conditions that are not represented in training data and difficult to replicate during field testing.

This guide lays out real price points from at-home MTHFR gene test kits and direct-access labs to doctor-ordered testing, then explains what you actually get for the fee per cost and results guidance.

In 2023, Jill Martin took a test that changed her life. She underwent genetic testing for breast cancer and learned she had a BRCA2 mutation, which increases one’s risk of developing breast and other ...

EGFR mutation testing is crucial for NSCLC treatment, but global disparities exist in access to comprehensive molecular diagnostics. Third-generation inhibitors and combination regimens improve ...

—Dr. McArthur of University of Texas Southwestern Medical School discusses the ideal time to pursue genomic testing and how it may be able to help guide treatment. (1:45) The Current and Future Roles ...

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly ...

Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the impacts of digital health care for patients, providers, and businesses. You can ...

Abstract: Mutation testing aims to simulate real-world defects, but existing tools often struggle to replicate method invocation defects accurately. To address this, we propose MIN (Method INvocation ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

A team led by Rutgers University-New Brunswick engineers has developed a portable device capable of detecting rare genetic mutations from a single drop of blood. The instrument, described in a study ...